Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Tong Ren Tang Technologies Co's Return-on-Tangible-Asset or its related term are showing as below:
STU:TNG'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 2.82 Med: 4.57 Max: 8.11
Current: 2.82
During the past 13 years, Tong Ren Tang Technologies Co's highest Return-on-Tangible-Asset was 8.11%. The lowest was 2.82%. And the median was 4.57%.
STU:TNG's Return-on-Tangible-Asset is ranked worse than 50.65% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 2.95
vs STU:TNG: 2.82
Tong Ren Tang Technologies Co (STU:TNG) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Tong Ren Tang Technologies Co Return-on-Tangible-Asset Related Terms
Tong Ren Tang Technologies Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tong Ren Tang Technologies Co Return-on-Tangible-Asset Chart
STU:TNG vs LLY, JNJ, ABBV: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 0.82% mean?
Tong Ren Tang Technologies Co (STU:TNG) has a Return-on-Tangible-Asset of 0.82% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Tong Ren Tang Technologies Co and its competitors. This is 82% below median its historical median of 4.57. Over the past decade, Tong Ren Tang Technologies Co's Return-on-Tangible-Asset has ranged from 2.82 to 8.11. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #510 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 50.6%.
Is Tong Ren Tang Technologies Co's Return-on-Tangible-Asset too high?
Tong Ren Tang Technologies Co's current Return-on-Tangible-Asset of 0.82% is 82% below median its 10-year median of 4.57. Over the past 10 years, this metric has ranged from a low of 2.82 to a high of 8.11. The Drug Manufacturers industry median Return-on-Tangible-Asset is 2.95. Tong Ren Tang Technologies Co's value of 0.82% is 72.2% below this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #510 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's Return-on-Tangible-Asset compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #510 out of 1007 companies for Return-on-Tangible-Asset. This places Tong Ren Tang Technologies Co in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.95. Tong Ren Tang Technologies Co's value of 0.82% is 72.2% below this benchmark. Historically, Tong Ren Tang Technologies Co's own Return-on-Tangible-Asset has ranged from 2.82 to 8.11 over the past decade. While the company's 10-year median is 4.57 vs. the industry median of 2.95, Tong Ren Tang Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 2.95, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current Return-on-Tangible-Asset of 0.82% is 72.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current Return-on-Tangible-Asset is 0.82%, which is 82% below median its own 10-year median of 4.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Tong Ren Tang Technologies Co (STU:TNG) has a current Return-on-Tangible-Asset of 0.82%. The stock's GF Value™ is €0.55, compared to a current price of €0.34 — trading 38.9% below its estimated fair value. The current Return-on-Tangible-Asset is 0.82%, which is 82% below median its 10-year median of 4.57 and 72.2% below the Drug Manufacturers industry median of 2.95. Tong Ren Tang Technologies Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (STU:TNG), the current Return-on-Tangible-Asset is 0.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (STU:TNG) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of €0.34 is trading 38.9% below its estimated GF Value™ of €0.55.
Key valuation signals for STU:TNG:
Return-on-Tangible-Asset: 0.82% (82% below median its 10-year median of 4.57)
GF Value™: €0.55 vs. price of €0.34 (38.9% below fair value)
Industry Position: 72.2% below the Drug Manufacturers median (#510 of 1007)
No single metric tells the full story. See the STU:TNG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
78GF Score
Get the complete analysis for STU:TNG
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:TNG has been successfully added to your 
